THE ECONOMIC IMPACT OF LINEZOLID FOR THE MANAGEMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN THE CHILEAN PREVISIONAL HEALTH INSTITUTIONS (ISAPRE)

被引：0
|
作者：
Mould-Quevedo, J. F. [1 ]
Vargas Zea, N. [2 ]
Diaz-Sotelo, O. D. [3 ]
Villamil Munevar, V. [3 ]
Ortiz, Vecino A. [4 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Pfizer SAS, Bogota, Colombia
[3] RANDOM Fdn, Bogota, DC, Colombia
[4] Johns Hopkins Univ, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
    Dirk Schürmann
    Sonja V. Sorensen
    Erwin De Cock
    Sandeep Duttagupta
    Ansgar Resch
    The European Journal of Health Economics, 2009, 10
  • [32] TREATMENT OF COMPLICATED SKIN AND SOFT-TISSUE INFECTIONS CAUSED BY RESISTANT BACTERIA VALUE OF LINEZOLID, TIGECYCLINE, DAPTOMYCIN AND VANCOMYCIN
    Eckman, Christian
    Dryden, Matthew
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) : 554 - 563
  • [33] Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
    Christian Eckmann
    Matthew Dryden
    European Journal of Medical Research, 15 (12)
  • [34] Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
    Schuermann, Dirk
    Sorensen, Sonja V.
    De Cock, Erwin
    Duttagupta, Sandeep
    Resch, Ansgar
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (01): : 65 - 79
  • [35] Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue Infections in France
    De Cock, E.
    Sorensen, S.
    Levrat, F.
    Besnier, J. -M.
    Dupon, M.
    Guery, B.
    Duttagupta, S.
    MEDECINE ET MALADIES INFECTIEUSES, 2009, 39 (05): : 330 - 340
  • [36] Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia
    Moghnieh, Rima
    Alothman, Adel F.
    Althaqafi, Abdulhakeem O.
    Matar, Madonna J.
    Alenazi, Thamer H.
    Farahat, Fayassal
    Corman, Shelby L.
    Solem, Caitlyn T.
    Raghubir, Nirvana
    Macahilig, Cynthia
    Stephens, Jennifer M.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2017, 10 (06) : 849 - 854
  • [37] ZINFORO (CEFTAROLINE FOSAMIL) VERSUS OTHER EMPIRIC INITIAL IV ANTIBIOTICS FOR COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI): A NETWORK META-ANALYSIS
    Rao, N.
    Gibson, E.
    Lawson, R. W.
    Goodall, J. J.
    VALUE IN HEALTH, 2016, 19 (07) : A408 - A408
  • [38] Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections
    Duane, Therese M.
    Huston, Jared M.
    Collom, Morgan
    Beyer, Adam
    Parli, Sara
    Buckman, Sara
    Shapiro, Mark
    McDonald, Amy
    Diaz, Jose
    Tessier, Jeffrey M.
    Sanders, James
    SURGICAL INFECTIONS, 2021, 22 (04) : 383 - 399
  • [39] Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
    Stevens, DL
    Smith, LG
    Bruss, JB
    McConnell-Martin, MA
    Duvall, SE
    Todd, WM
    Hafkin, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3408 - 3413
  • [40] Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
    Stephens, Jennifer M.
    Gao, Xin
    Patel, Dipen A.
    Verheggen, Bram G.
    Shelbaya, Ahmed
    Haider, Seema
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 447 - 457
12345